BioSpace News Archive

Press Releases

Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

January 8, 2026
·
11 min read
Press Releases

Epirium Bio Announces Follow-on Phase 1 Results in Older Adult Participants for MF-300, a First-In-Class, Oral 15-PGDH Enzyme Inhibitor, for the Treatment of Sarcopenia

January 8, 2026
·
4 min read
Press Releases

Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference

January 8, 2026
·
6 min read
Press Releases

Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital

January 8, 2026
·
5 min read
Press Releases

Frazier Life Sciences Announces Multiple Promotions to Key Senior Level Positions

January 8, 2026
·
3 min read
Press Releases

INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™

January 8, 2026
·
4 min read
Press Releases

Ukko Provides 2026 Strategic Outlook and Highlights Recent Milestones

January 8, 2026
·
3 min read
Press Releases

JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 8, 2026
·
2 min read
Press Releases

Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S

January 8, 2026
·
5 min read
Press Releases

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS

January 8, 2026
·
3 min read